Market Closed -
Other stock markets
|
After market 03:21:47 pm | |||
0.879 EUR | -1.79% | 0.886 | +0.80% |
07:00am | Pharming Group N.V. Provides Revenue Guidance for 2024 | CI |
07:00am | Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 263M 283M | Sales 2025 * | 302M 325M | Capitalization | 603M 648M |
---|---|---|---|---|---|
Net income 2024 * | 1M 1.07M | Net income 2025 * | 14M 15.04M | EV / Sales 2024 * | 1.94 x |
Net cash position 2024 * | 90.86M 97.63M | Net cash position 2025 * | 119M 128M | EV / Sales 2025 * | 1.6 x |
P/E ratio 2024 * |
-298
x | P/E ratio 2025 * |
40.7
x | Employees | 382 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.01% |
Latest transcript on Pharming Group N.V.
1 day | -1.79% | ||
1 week | -2.12% | ||
Current month | +0.29% | ||
1 month | -10.67% | ||
3 months | -20.09% | ||
6 months | -19.51% | ||
Current year | -14.74% |
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 20-11-15 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.05% | 7 M€ | -.--% | - | |
0.02% | 0 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.879 | -1.79% | 13 549 553 |
24-05-07 | 0.895 | -0.56% | 6,497,833 |
24-05-06 | 0.9 | +0.17% | 4,498,156 |
24-05-03 | 0.8985 | +0.06% | 4,659,264 |
24-05-02 | 0.898 | +2.45% | 2,763,190 |
Real-time Euronext Amsterdam, May 08, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.74% | 650M | |
+33.16% | 700B | |
-4.94% | 358B | |
+18.96% | 330B | |
+3.40% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.13% | 161B | |
-1.82% | 157B |
- Stock Market
- Equities
- PHARM Stock